With the GemCode Platform, 10x Genomics researchers can now find structural variants, haplotypes, and other valuable long range information while leveraging existing sequencing workflows.
Revolutionizing Type 2 Diabetes and Obesity
Intarcia's device is a matchstick-sized osmotic pump that delivers GLP-1 (Glucagon-Like Peptide-1) in a manner that avoids the need for regular, painful injections while producing efficacy and tolerability results.
Developing Therapeutic Antibodies to Maximize Efficacy
Alder's ALD403 is a novel monoclonal antibody targeting calcitonin gene-related peptide (CGRP) in Phase 3 trials for the prevention of migraine headaches.
Protecting People From Food Allergens
Aimmune’s characterized oral desensitization immunotherapy (CODIT™) system combines proprietary product candidates with gradual, controlled up-dosing protocols to obtain meaningful desensitization to food allergens.
Addressing Glaucoma With Triple-Action Eyedrops
Aerie is developing first-in-class once-daily eye drops with the ability to reduce intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension.
Reversing Tumors Associated With Immunosuppression
Arcus is pursuing small-molecule and protein-based therapeutics to block active immunosuppression pathways and selectively stimulate the tumor-killing activity of effector immune cells.